Podchaser Logo
Home
Mad in America: Science News

James Moore

Mad in America: Science News

A weekly Science, Health and Fitness podcast
Good podcast? Give it some love!
Mad in America: Science News

James Moore

Mad in America: Science News

Episodes
Mad in America: Science News

James Moore

Mad in America: Science News

A weekly Science, Health and Fitness podcast
Good podcast? Give it some love!
Rate Podcast

Episodes of Mad in America

Mark All
Search Episodes...
In this 30-minute podcast, Peter Simons reports on the latest scientific articles in psychiatry. The goal is to provide more detail than is usually found in conventional research news and to help listeners understand how to interpret the findin
In this 30-minute podcast, Peter Simons reports on the latest scientific articles in psychiatry. The goal is to provide more detail than is usually found in conventional research news and to help listeners understand how to interpret the findin
In this 30-minute podcast, Peter Simons reports on the latest scientific articles in psychiatry. The goal is to provide more detail than is usually found in conventional research news and to help listeners understand how to interpret the findin
Peter Simons covers a study in Nature finding that the positive results of psychiatry’s brain imaging studies are false; a study demonstrating that more than half of negative antidepressant trials remain unpublished or are misleadingly “spun”
Peter Simons covers a study that found both therapy and medication to have very limited effectiveness; an article suggesting that general practitioners need to prescribe fewer antidepressants; a study that concluded no brain imaging test has b
Peter Simons covers a clinical trial that found lithium ineffective at preventing suicide attempts, an essay by Allen Frances on the overdiagnosis of depression and overprescription of antidepressants, a review of the ineffectiveness and dang
Peter Simons covers articles about the validity of psychiatric diagnoses, the medicalization of normal human experiences like grief, and how the pharmaceutical industry co-opts feminist messaging to gain approval for ineffective drugs. Kenn
This week, Peter Simons covers a study about the controversial practice of placebo run-in periods in antidepressant studies, a study about withdrawal symptoms being mistaken for relapse, and a book chapter that addresses stigma and discriminat
This week, Peter Simons covers studies examining whether mental health literacy and essentialist thinking are associated with stigma against those with mental health problems. He also covers a study finding that psychotherapy is ineffective fo
This week, Peter Simons covers a study that found prolactin-increasing antipsychotics associated with increased breast cancer risk, an analysis that found no convincing evidence that screening for depression improves outcomes, and the continui
This week, Peter Simons covers studies on the biological mechanism behind antipsychotic drugs' association with dementia; surprising brain imaging findings with implications for antidepressant effectiveness; bias in the psychotherapy literatur
This week, Peter Simons covers three studies about financial ties to the pharmaceutical industry in editorial and commentary writers in medical journals. These conflicts of interest create biased research literature that helps pharma push pote
This week, Peter Simons covers two articles about the pharmaceutical industry's influence on drug regulators, and an article finding that newborn babies experience antidepressant withdrawal if their mothers took SSRIs while pregnant. 75% of
This week, Peter Simons covers three new articles which suggest that “relapse” in the drug trials for both antidepressants and antipsychotics is likely caused by sudden withdrawal. This contradicts the notion that the drugs have protective eff
This week, Peter Simons covers a BMJ investigation that found the FDA's "accelerated approval" process has left ineffective drugs on the market, some for more than 20 years, without follow-up studies to demonstrate efficacy. He also covers fur
This week, Peter Simons covers a BMJ story that concluded 20% of health research is fraudulent, as well as a Lancet Psychiatry piece that critiques the research on long-acting injectable antipsychotics and debunks the claim that they are bett
This week, Peter Simons covers two articles in which researchers critique the medical model of psychiatry and propose alternatives. Researchers Critique the Medical Model, Propose an Alternative Medical Sociologist Details the Failures of Am
This week, Peter Simons provides an update on the FDA's controversial approval of Alzheimer's drug aducanumab, a new guideline for psychoeducation about ADHD, a study linking poverty rates and youth suicide, and an article providing essential
This week, Peter Simons covers an article from a trauma survivor who describes the harms of screening, an article that found no genetic links to suicide risk, and an article that found animals were far better than humans at supporting grieving
This week, Peter Simons covers the latest news on the FDA's approval of failed Alzheimer's drug aducanumab, against the recommendation of its own advisory committee, which led to three members of the committee resigning in protest. He also cove
  This week, Peter Simons covers an article finding that short, simple psychotherapy when discontinuing antidepressants is just as good at preventing relapse as continuing the drug. He also covers a study that found little difference in inflamm
This week, Peter Simons covers an article finding that anticholinergic drugs are linked to cognitive impairment, an article by Allen Frances about overprescription of antidepressants, and an article warning about reductionistic assumptions abo
This week, Peter Simons covers an article in JAMA by FDA advisory committee members that reveals ethical issues with the FDA's collaboration with pharmaceutical company Biogen to re-analyze their two failed trials of Alzheimer's disease drug a
This week, Peter Simons covers a study that found evidence for overdiagnosis of ADHD in children and adolescents, a study about suicide prevention in men, and findings regarding race and gender in PTSD. Study Confirms Overdiagnosis of ADHD
This week, Peter Simons covers a Cochrane review that found no good evidence on how antidepressant withdrawal, a study that found that antidepressants are not useful for back pain, and a study that found that having financial debt led to later
Rate

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features